Intestinally-derived lipoproteins: Metabolism and clinical significance
- 1 September 1991
- journal article
- review article
- Published by Wiley in Diabetes/Metabolism Research and Reviews
- Vol. 7 (3) , 191-208
- https://doi.org/10.1002/dmr.5610070308
Abstract
No abstract availableThis publication has 91 references indexed in Scilit:
- Risk Factors for Coronary Artery Disease in Healthy Persons with Hyperinsulinemia and Normal Glucose ToleranceNew England Journal of Medicine, 1989
- Intestinal Synthesis, Secretion, and Transport of LipoproteinsAnnual Review of Physiology, 1983
- Intermediate-density lipoprotein and cholesterol-rich very low density lipoprotein in angiographically determined coronary artery disease.Circulation, 1981
- Uptake of chylomicron remnants causes cholesterol accumulation in cultured human arterial smooth muscle cellSBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1981
- Atherogenesis: a postprandial phenomenon.Circulation, 1979
- Hypertriglyceridemia Associated with Deficiency of Apolipoprotein C-IINew England Journal of Medicine, 1978
- Human chylomicron apolipoprotein metabolismBiochemical and Biophysical Research Communications, 1978
- A protein cofactor of lecithin:Cholesterol acyltransferaseBiochemical and Biophysical Research Communications, 1972
- A specific apoprotein activator for lipoprotein lipaseBiochemical and Biophysical Research Communications, 1970
- Hyperlipidæmia : a Cause of Decreased Oxygen SaturationNature, 1963